A Virtual Reality Tour: Diagnostic Strategies, Evolving Treatments, and Individualized Management of Psoriatic Arthritis

View Activity

FACULTY

Anthony M. Reginato, PhD, MD
Director Rheumatology Research and Musculoskeletal Ultrasound
Director, Rheumatology Fellowship Program at Brown University
Acting Chief, Division of Rheumatology, Providence VAMC
Associate Professor in Medicine, The Warren Alpert School of Medicine
Providence, RI

Andreas Reimold, MD
Professor
Rheumatic Diseases Division
Department of Internal Medicine
University of Texas Southwestern Medical Center
Dallas, TX

PROGRAM OVERVIEW

This case-based enduring activity will cover the treatment and management of patients with psoriatic arthritis.

TARGET AUDIENCE

This activity is intended for rheumatologists and other healthcare professionals involved in the management of patients with psoriatic arthritis.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss diagnostic best practices in PsA, particularly strategies that allow for earlier diagnosis
  • Describe the comorbidities associated with PsA including CVD and their importance in the individualization of patient management
  • Review the mechanisms of action and efficacy/safety profiles of new and emerging biologics for the treatment of PsA with an emphasis on musculoskeletal and skin manifestations in addition to CVD and quality of life (QoL) outcomes
  • Discuss strategies designed to individualize therapy through improved communication amongst the members of the patient care team, as well as with their patients

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the treatment and management of patients with psoriatic arthritis.

CNE Credits:
1.5 ANCC Contact Hour(s)

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Reginato receives salary from the University Medicine Foundation, Inc., and is on the speakers bureau for Lilly.
Dr. Reimold has served as a consultant for Lilly, and has received research grants from Abbvie, Novartis, Genentech, Pfizer, BMS, Janssen, and HGS.

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a CCM nurse reviewer.

The reviewer of this activity has nothing to disclose

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP Educational Development for Med Learning Group has nothing to disclose.
Lisa Dorin, Senior Program Manager for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Reginato and Dr. Reimold may mention the use of medications for both FDA-approved and non-approved indications

METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate via email within 30 days.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

RELEASE DATE: November 17, 2017

EXPIRATION DATE: November 17, 2018

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.